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Abstract: The aortic arch presents specific challenges to endovascular repair. Hybrid repair 
is increasingly evolving as an alternative option for selected patients, and promising initial 
results have been reported. The aim of this study was to introduce our experiences and 
evaluate mid-term results of supra aortic transpositions for extended endovascular repair of 
aortic arch pathologies. From December 2002 to January 2008, 25 patients with thoracic 
aortic  aneurysms  and  dissections  involving  the  aortic  arch  were  treated  with  hybrid 
endovascular treatment in our center. Of the 25 cases, 14 were atherosclerotic thoracic 
aortic aneurysms and 11 were thoracic aortic dissection. The hybrid repair method included 
total-arch  transpositions  (15  cases)  or  hemi-arch  transpositions  (10  cases),  and 
endovascular procedures. All hybrid endovascular procedures were completed successfully. 
Three  early  residual  type-I  endoleaks  and  one  type-II  endoleak  were  observed.  Stroke 
occurred in three patients (8%) during the in-hospital stage. The perioperative mortality rate 
was  4%;  one  patients  died  post-operatively  from  catheter  related  complications.  The 
average follow-up period was 15 ±  5.8 months (range, 1–41 months). The overall crude 
survival rate at 15 months was 92% (23/25). During follow-up, new late endoleaks and 
stent-raft related complications were not observed. One case (4%) developed a unilateral 
lower limb deficit at 17 days and was readmitted to hospital. In conclusion, the results are 
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encouraging  for  endovascular  aortic  arch  repair  in  combination  with  supra-aortic 
transposition  in  high  risk  cases.  Aortic  endografting  offers  good  mid-term  results.  
Mid-term results of the hybrid approach in elderly patients with aortic arch pathologies  
are satisfying. 
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1. Introduction 
The conventional surgical repair of thoracic aortic aneurysms and dissections remains a high risk 
procedure [1,2]. Based on the eight largest recent researches published (with over 40 patients) [3–10], 
the  30-day  stroke/death  rate  after  aortic  arch  surgical  repair  is  up  to  25.6%  (mean  17.5%).  The 
introduction  of  endovascular  stent  graft  technology  has  reached  an  evolutionary  threshold  for  the 
treatment of complex aortic  diseases.  The aortic arch presents specific challenges  to endovascular 
repair, which mainly arise from the involvement of the supra-aortic branches and the tight inner curve. 
Inoue et al. reported one case of triple-branched stengraft [11]
 and Chuter and colleagues reported a 
branched  stentgraft  to  the  innominate  artery  [12,13].  However,  these  new  designs  are  still  at  an 
experimental  stage.  Hybrid  repair,  which  constitutes  a  combination  of  open  supra-aortic  branch 
revascularization and endovascular aortic repair, has increasingly evolved as an alternative option for 
selected patients, and promising initial results have been reported [14–18]. The aim of this study was to 
introduce our expriences  and evaluate mid-term results of supra aortic transpositions for extended 
endovascular repair of aortic arch pathologies. 
2. Methods 
From December 2002 to January 2008, 25 patients with thoracic aortic aneurysms and dissections 
involving the aortic arch were treated with hybrid endovascular treatment in our center. Preoperative 
planning was at the discretion of the operating surgeon and was based upon contrast enhanced CT 
scanning  with  1.5  mm  cuts  and  three-dimensional  reconstruction  that  allowed  accurate,  centerline 
measurements of the aorta. As a prerequisite for successful stent-graft placement, a proximal landing 
zone of at least 1.5 cm along the curvature of the aortic arch was necessary. All patients underwent risk 
evaluation according to EuroSCORE guidelines [19]. Patients who were not suitable for endografting 
and those at low risk for surgery were treated by open surgery (three patients during the same period).  
The average age of the patients was 71.5 ±  9.9 years (range, from 50 to 83 years), and the ratio 
(male:female) was 5.5:1. Risk factors of the patients are shown in Table 1. Among 25 cases, 14 (56%) 
were  atherosclerotic  thoracic  aortic  aneurysms,  the  average  length  of  aneurysms  was  
242.33 ±  82.34  mm;  11  (44%)  were  aortic  dissection,  three  (12%)  were  type  A  thoracic  aortic 
dissection, 8 (32%) were type B thoracic aortic dissection, of which seven were chronic phase and one 
was acute phase. The acute phase was defined as within two weeks after symptom onset; the subacute 
phase as the following two-month period; and the chronic phase as anything thereafter. The interval Int. J. Mol. Sci. 2010, 11                       
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from onset of type B thoracic aortic dissection to treatment was 2–7 months. The average maximum 
aortic diameter was 64 ±  11.3 mm. None of the pathologies were a result of trauma.  
Table 1. Risk factors in patients. 
Risk factors  Number of patients  Percentage (%) 
Age over 70  17  68 
Severe cardiac impairment: cardiac valvulopathy, 
previous coronary bypass and/or MI 
12  48 
Chronic pulmonary disease: (FEV1 ≤ 1l)  10  40 
Neurological dysfunction  3  12 
Surgery on thoracic aorta  7  28 
In  order  to  distinguish  from  Ishimaru’s  anatomical  aortic  classification  [20]  using  antegrade 
numbering, we propose a retrograde landing zone classification [21]. This classification is based on 
pathophysiology and reflects the extension of the disease and case complexity, with respect to the need 
for  transposition.  We  define  four  proximal  landing  zones  as  seen  in  Figure  1.  An  endografting 
procedure  at  Zone  3  is  an  ideal  situation  and  requires  no  surgical  complementary  step  for  both 
aneurysms and dissections.  Starting at Zone 2 requires either coverage or transposition of the left 
subclavian artery (LSA). If the origin of the left common carotid artery (CCA) (Zone 1) is involved, 
transposition to the right CCA via a carotido-carotid bypass must be performed. We call this adjunctive 
procedure a hemiarch transposition. If the disease extends the full length of the aortic arch, requiring 
coverage of the innominate artery (IA), a bypass to the IA and left CCA is performed through a median 
sternotomy  from  the  ascending  aorta.  We  refer  to  this  as  total-arch  transposition  (Figure  2).  The 
terminology of hemi-arch and total-arch transposition is used in order to simplify the discussion, thus 
avoiding repetition of the different bypasses performed. 
Figure 1. The proximal landing zone classiﬁcation. 
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Figure 2. The intra-operative view of the implanted endograft (left) and the Angiogram 
(right) demonstrating the reconstruction of the total-arch transposition. 
   
We  performed  15  total-arch  transpositions  and  10  hemi-arch  transpositions.  For  the  total-arch 
transpositions, the endografts were deployed at a second step: 1 week following the creation of the 
proximal landing zone. We always used a femoral percutaneous access and an additional percutaneous 
humeral approach was used in some instances to mark the origin of the native IA and LSA. Carotid and 
vertebral artery circulation were assessed before operation. During the transposition procedure, the 
stump pressure was checked before clamping the arch vessels. 
Hemi-arch transposition was performed via a vertical 4 cm cervical approach to both CCAs. Then 
an 8 mm Dacron graft (Braun Unigraft, Melsungen) was implanted between two CCAs in a U shape 
anterior  to  the  trachea.  The  strategy  of this  procedure was  to  perform  an end-to-side anastomosis 
between  the  left  CCA  and  the  brachiocephalic  trunk.  Afterwards,  an  end-to-side  anastomosis was 
performed between the LSA and the already transposed LCCA. Total arch transposition is performed 
through a median sternotomy. A 12 mm Dacron bifurcated graft (Braun Unigraft, Melsungen) was 
implanted on the ascending aorta as proximal as possible, using lateral clamping. An 8 mm branch 
anastomosed end-to-end to the IA, while another 8 mm branch was anastomosed the same way to the 
right CCA. The proximal stumps of these vessels were clamped during the anastomosis and sutured 
with a 5/0 prolene (Ethicon, Inc, Somerville, NJ, USA) suture after the bypass was finished in order to 
reduce the clamping time. Depending on the patient’s anatomy, the graft was passed in front or behind 
the innominate vein, which can be divided or reconstructed if necessary. The LSA was not bypassed 
unless  the  vertebral  artery  was  dominating,  since  it  is  often  hard  to  reach  through  a  standard 
sternotomy. Moreover, a patent LSA may serve as access to the aneurysm, when coiling was necessary 
to treat a residual type I endoleak. A retrograde type II endoleak will appear only if there was an 
outflow from the sac, such as created by patent intercostal arteries, which are normally thrombosed. In 
only one case we observed a type II endoleak that was easily treated by percutaneous occlusion of the 
LSA (Figure 3). Endoleaks are defined as follows: type I include leaks from the proximal and distal 
seal zones, type II are secondary to patency of aortic branches (intercostal arteries, lumbars, etc.) [22]. 
Following total-arch transposition, markers (metal clips) were placed at the proximal anastomosis to 
the arch, to define the proximal extent of the proximal landing zone. Int. J. Mol. Sci. 2010, 11                       
 
 
4691 
Figure 3. Coiling of the left subclavian artery after total arch repair [23]. 
 
 
Three  different  commercially  available  stent-graft  systems  were  used,  as  shown  in  Table  2. 
Endovascular  procedures  were  performed  under  general  anesthesia.  In  the  majority  of  patients,  a 
transfemoral approach was chosen. If the diameter of the external iliac artery was not large enough, the 
common  iliac  artery  was  used  for  arterial  access.  Stent-graft deployment was  routinely performed 
under hypotonic conditions (systolic pressure < 90 mmHg). We did not use adenosine induced transient 
cardiac asystole. Endografts were oversized by 20% for aneurysms and 10% for dissections. The distal 
diameter of the endograft was initially slightly reduced with non-tapered devices. Since this series, we 
have been treating dissections with a tapered endograft whose 24 mm distal diameter better fits the 
distal landing zone. Stent-graft related data are shown in Table 3. We avoided using dilatation balloons 
unless it was necessary due to a residual endoleak. This was especially true for dissections. 
Table 2. The relevant characteristics of the three proximal device implants used. 
Device  Patients treated, 
%( n) 
Proximal bare 
spring 
Deployment strategy 
Talent  
(Medtronic, minneapolis, Minn) 
32 (8)  With  pullback 
Ankura  
(Lifetech, Shenzhen, China) 
24 (6)  With  pullback 
Zenith TX2  
(Cook, Bjaeverskov, Denmark) 
44 (11)  without  Pullback and then 
release of trigger wire 
Table 3. Stent-graft related data. 
  Covered length  Proximal 
diameters 
Distal diameters  Graft number 
aneurysm  280.33 ±  82.34 
(184–388) 
43.33 ±  2.07  38.00 ±  2.19  2.5 ±  1.05 
dissection  223.33 ±  111.01 
(113–335) 
43.33 ±  2.31  42.00 ±  2.00  2 ±  1 Int. J. Mol. Sci. 2010, 11                       
 
 
4692 
Following hospital discharge, patients were regularly contacted either by mail or telephone and they 
were asked to undergo both CT-scan and plain X-ray examinations at 3 (in case of post-operative 
residual minor type 1 endoleak), 6, 12, 18 and 24 months post-operatively, and yearly there after. Data 
such as pre-operative size, patients’ condition, risk factors, and post-operative control information, etc., 
were collected during regular working meetings, and were put together in a single Excel file. We 
calculated crude rates of survival, neurological complications and endoleaks because the study was not 
large enough to carry out a life-table analysis. 
3. Results 
3.1. Duration of Hospital Stay 
3.1.1. Surgical Procedure 
All patients recovered uneventfully without any serious neurologic injury after aortic debranching. 
One  patient  in  the  hemi-arch  transposition  group  suffered  a  minor  stroke,  but  was  eventually 
discharged successfully. In the total arch transposition group, one proximal dissection occurred at the 
site of lateral clamping, which sealed spontaneously. 
3.1.2. Stent-Graft Placement 
All  endovascular  procedures  were  completed  successfully.  One  worsening  minor  stroke  was 
observed in the hemi-arch transposition group, while no neurological complication occurred in the 
group  of  total  arch  exclusion.  During  the  deployment,  the  stent  graft  had  not  misplacement.  We 
observed  three  early  residual  type-I  endoleaks  (12%),  which  were  left  untreated  since  they  may 
thrombose  spontaneously  in  the  post-operative  course.  The  first  residual  endoleak  thrombosed 
spontaneously and the second was successfully treated by graft extension. The third was due to an 
uncovered entry tear in the ascending aorta and would have required total arch transposition, which 
was rejected by the patient. We also had one type-II endoleak in an aneurysm from LSA, which was 
successfully coiled after one week. We had no case of early paraplegia. 
Stroke occurred in three patients (8%) during the in-hospital stage; one patient had a minor stroke 
within 48 h due to the occlusion of the left CCA bypass, which was resolved by a cervical carotid-
carotid  bypass.  The  perioperative  mortality  rate  was  4%;  one  patient  died  post-operatively  from 
catheter related complications: The patient died at three days from multiorgan failure after rupture of 
the descending of the aorta.  
3.2. Follow-up Period 
The average follow-up period was 15 ±  5.8 months (range from 1–41 months), and all patients 
adopted follow-up regularly. Three-dimensional CT-scan and X-ray examinations were obtained for all 
the  patients  before  their  discharge  to  act  as  control  images.  The  overall  crude  survival  rate  at  
15 months was 92% (23/25). Another patient with chronic obstructive pulmonary disease (COPD) died 
three months after the procedure because of acute respiratory failure. Int. J. Mol. Sci. 2010, 11                       
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During follow-up, new late endoleaks were not observed. The aneurysmal sac exclusion rate was 
100%. The rate of occlusion in thoracic false lumen was 91%, while we observed seven cases (28%) 
patent  abdominal  false  lumens,  of  which  the  maximum  aortic  diameter  was  <50  mm.  Endograft 
migration, fracture, and stent-raft related complications such as aorto-esophageal fistula were also not 
observed.None of the patients had new cerebral neurological adverse events. One case (4%) developed 
a unilateral lower limb deficit at 17 days and was readmitted to hospital. According to independent 
neurological assessment, this deficit could be due to medullar ischemia, based on cerebral and medullar 
MRI findings.  
4. Discussion 
Since the first description of revascularization of the left carotid and sbuclavian artery from the 
ascending  aorta  prior  to  stent  grafting,  only  case  reports  and  small  case  series  have  been  
published  [24–30].  No  comparative  randomized  or  non-randomized  studies  of  combined  open 
debranching and endovascular procedures with other conventional treatment strategies for aortic arch 
repair  have  been  identified.  Furthermore,  mid-term  and  long-term  results  are  still  awaited.  Our  
mid-term results of alternative treatment approaches for aortic arch pathologies are satisfying. This 
hybrid approach provides safe and effective treatment for patients at high risk for conventional repair. 
We recommend additional transposition of LSA when it supplies coronary circulation through the 
left internal mammary artery, when the contralateral vertebral artery (VA) is stenosed or in a diseased 
vertabro-basilar system. We also recommend transposing the LSA in association with the left CCA 
when they are included in the aneurysm, except during total transpositions since the LSA is difficult to 
reach by median sternotomy. In all other cases, LSA transposition is only required later if the coverage 
becomes symptomatic. Great vessel transposition appears to be safe. There were no major strokes or 
deaths related to transposition. There was one early death (4%) after the endovascular step, which was 
either access or guide-wire related.  
In the total arch exclusion group, no immediate neurological complications occurred during either 
surgical or endovascular steps. On the other hand, in the hemi-arch exclusion group, we observed one 
major stroke. This may be due to catheter manipulation in front of a patent innominate artery ostium, in 
a patient with an atherosclerotic aorta. A possible way to reduce embolic complications may be to 
perform pre-operative trans-esophageal echography to better select the patients. We should also pay 
attention to reduce cross-clamping times of the brain supplying vessels by as much as possible, and 
furthermore, the absence of substantial atherosclerotic disease in the wall of the asending aorta in total 
arch rerouting procedures. Without doubt, the risk of embolism is present in all these procedures and 
careful manipulation of central vessels as well as minimizing the cross-clamp times, in order to not 
exceed the ischemic frame of cerebral tissue, is mandatory for success [31]. 
Total arch transposition allows availability of a longer proximal landing zone, easily reaching 3 cm 
in length for a better anchoring of the endograft. It also avoids stentgraft deployment within the arch 
curvature, which may cause endoleaks and migration. In selected cases of conical or larger aortas 
exceeding 40 mm in diameter, the banding technique may be useful in association with total arch 
transposition to allow a better proximal landing zone. Int. J. Mol. Sci. 2010, 11                       
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We prefer a staged procedure for the following reasons: the operating time is decreased; bleeding 
volume  is  lowered;  the  risk  of  graft  infection  may  be  lowered,  since  endovascular  and  imaging 
manoeuvers are not performed in front of an open chest. Considering our encouraging results, we have 
decided  in  our  department  to  extend  the  use  of  total  arch  transposition  with  acute  type  A  aortic 
dissection. We are combining the replacement of the ascending aorta with the transposition of the IA to 
the ascending aortic graft. This allows secondary arch coverage for recalcitrant dissection. 
The future of this challenging approach is dependent on whether the endografting technology will 
be reliable or not [32]. Improvement of stent-grafting is needed in terms of flexibility to improve aortic 
arch navigation and reduce the embolic risk.  
In summary, this study analyzed the mid-term results of endovascular repair of aortic arch aneurysm 
and dissection. The results are encouraging for endovascular aortic arch repair in combination with 
supra-aortic transposition in high risk cases. Combined treatment for high risk cases offers as good 
results  as  seen  for  conventional  surgery  for  low  risk  patients.  Aortic  endografting  offers  good  
mid-term results. The mid-term results of the treatment approach in elderly patients with aortic arch 
pathologies at high risk are satisfying. Nevertheless, meticulous technique is mandatory in order to 
avoid diverse complications. Thus, the long-term utility of this technology awaits further investigation, 
although intermediate-term results are encouraging in high-risk patients. 
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